Immunotherapy - Wikipedia, the free encyclopedia
^"Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction."
Allergen immunotherapy - Wikipedia, the free encyclopedia
Double-blind, placebo-controlled studies in Europe using high-dose sublingual immunotherapy have shown benefit. [26] However, this form of treatment is not approved or licensed in ...
MJA: Position statement, Specific allergen immunotherapy for asthma
Rationale for using immunotherapy for asthma: Asthma is an inflammatory disease characterised by the presence of cells such as eosinophils, mast cells, basophils, and CD25+ T ...
Immunotherapy: Tumor Immunology: Merck Manual Professional
A new approach using T cells genetically modified to express receptors that recognize ... A novel approach to cancer treatment combining immunotherapy and conventional chemotherapy has ...
Medicament, Particularly an Anti-Cancer Medicament, for Treatment ...
Patent application title: Medicament, Particularly an Anti-Cancer Medicament, for Treatment Using Immunotherapy, Particularly Autologous Inventors: Daniel Ciocca Patrick ...
Pollenguard
The primary benefit to using homeopathic sublingual immunotherapy is the ability to treat more patients, including children, asthmatics and others who aren't able to tolerate ...
Tumor Immunotherapy Program
Our Tumor Immunotherapy Laboratory focuses on research projects involving basic virology using recombinant technology to construct poxvirus vectors, in vitro T-cell assays to ...
Arch Otolaryngol Head Neck Surg -- Immunotherapy of Established Murine ...
To date, no preclinical studies, to our knowledge, using immunotherapy with dendritic-tumor cell fusion against squamous cell carcinoma (SCC) have been reported.
Immunotherapy for Cancer - Conclusion
Nishiyama T, Tachibana M, Horiguchi Y, et al. Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-2 peptide.
Genitope Corporation Phase 2 Data Using Personalized Immunotherapy for ...
Free Online Library: Genitope Corporation Phase 2 Data Using Personalized Immunotherapy for Initial Treatment of Non-Hodgkin's Lymphoma Presented at American Society of Clinical ...
